Menu Search
Equities

Fresh2 Group Ltd

FRES:NAQ

Fresh2 Group Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)1.21
  • Today's Change0.19 / 18.63%
  • Shares traded1.00
  • 1 Year change-87.26%
  • Beta1.2470
Data delayed at least 15 minutes, as of Nov 20 2024 19:51 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Fresh2 Group Limited is engaged in the business-to-business e-commerce and supply chain sectors. The Company employs an advanced supply chain management system, establishing direct connections with suppliers worldwide. By eliminating intermediaries and facilitating direct supplier-to-restaurant interactions, the Company creates a platform that offers new avenues of discovery and more pricing options for both restaurants and suppliers. Its business operations are built around an advanced e-commerce platform that connects food suppliers and supermarket operators and restaurant owners in the United States. Its platform includes mobile applications and a Website, providing clients with convenient access to a range of Asian food and foodservice products and ingredients. The Company offers various choices of products and find restaurant suppliers, such as disposable, dry goods, beverage, janitorial, equipment, meat, vegetables, seafood, dairy, and more.

  • Revenue in USD (TTM)1.62m
  • Net income in USD-13.43m
  • Incorporated2010
  • Employees75.00
  • Location
    Fresh2 Group Ltd880 3Rd Ave,Floor 7NEW YORK 10022United StatesUSA
  • Phone+1 (917) 397-6890
  • Websitehttp://www.anpac.cn/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.